Katja Richter, CEO of the company join the Family Day 2016 in Bonn. The FD16 (#FD16) is an invitation-only conference from the High-Tech Gründerfonds for networking of Germany’s best founders and CEOs from more than 266 HTGF portfolio companies with well known global players and the venture capital scene in Europe.

Heppe Medical Chitosan GmbH introduce a new version of the company brochure. Find compact information about our philosophy our quality and our products.

A successful research project of HMC and his cooperation partner ITM from Technical University of Dresden was mentioned in a special issue of the innovation report of the central innovation programm for medium sized companys "ZIM-project" in Germany. The whole article can be read under the following link:

www.zim-bmwi.de - report

While the oil is slowly but surely running out, renewable resources are becoming increasingly important. In future, the biological production of raw materials has to play an even greater role to meet the needs in an environmentally friendly manner. An international consortium of researchers and companies, including your organisation, now rises to this challenge. Its goal is the biotechnological production of so-called chitosans, which are used as raw materials for medicine, agriculture, water treatment, cosmetics, paper and textile industries as well as many other fields of application. To tap this potential, the European Commission supports the research project "Nano3Bio" with a total of almost 9 million Euros up to 2017.

In march 2012 Bruno Sarmento and José das Neves published a comprehensive collection of interesting articles about chitosan and its possible applications for biopharmaceutical products. The title of the anthology is:  „Chitosan-Based Systems for Biopharmaceuticals: Delivery, Targeting and Polymer Therapeutics“.